I agree that this site is using cookies. You can find further informations here.
X
Mesenbrink, Peter
86  results:
Search for persons X
?
1

Machine learning approaches to enhance diagnosis and stagin..:

McTeer, Matthew ; Applegate, Douglas ; Mesenbrink, Peter...
PLOS ONE.  19 (2024)  2 - p. e0299487 , 2024
Link: https://doi.org/10.1371/..
 
?
2

Developing generic templates to shape the future for conduc..:

Gidh-Jain, Madhavi ; Parke, Tom ; König, Franz...
Trials.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

A deep-learning-based model for assessment of autoimmune he..:

Ercan, Caner ; Kordy, Kattayoun ; Knuuttila, Anna...
Virchows Archiv.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

Regulatory Issues of Platform Trials: Learnings from EU‐PEA..:

Nguyen, Quynh Lan ; Hees, Katharina ; Hernandez Penna, Sabina...
Clinical Pharmacology & Therapeutics.  116 (2024)  1 - p. 52-63 , 2024
Link: https://doi.org/10.1002/..
 
?
5

MRI BIOMARKERS OF KNEE OSTEOARTHRITIS PROGRESSION: RESULTS ..:

Collins, Jamie E. ; Mesenbrink, Peter ; Jin, Rui...
Osteoarthritis and Cartilage.  32 (2024)  - p. S110-S111 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Lessons for the setting of an international integrated rese..:

Pericàs, Juan M ; de Sena, Elena ; Tacke, Frank...
Journal of Hepatology.  78 (2023)  - p. S819 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Platform trials to overcome major shortcomings of tradition..:

Pericàs, Juan M. ; Tacke, Frank ; Anstee, Quentin M....
Journal of Hepatology.  78 (2023)  2 - p. 442-447 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Designing an exploratory phase 2b platform trial in NASH wi..:

Meyer, Elias Laurin ; Mesenbrink, Peter ; Di Prospero, Nicholas A....
PLOS ONE.  18 (2023)  3 - p. e0281674 , 2023
Link: https://doi.org/10.1371/..
 
?
9

Decision rules for identifying combination therapies in ope..:

Meyer, Elias Laurin ; Mesenbrink, Peter ; Dunger‐Baldauf, Cornelia...
Pharmaceutical Statistics.  21 (2022)  3 - p. 671-690 , 2022
Link: https://doi.org/10.1002/..
 
?
10

On model-based time trend adjustments in platform trials wi..:

Bofill Roig, Marta ; Krotka, Pavla ; Burman, Carl-Fredrik...
BMC Medical Research Methodology.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
11

Longitudinal ALT trajectories are generally stable among pa..:

Fried, Michael ; Munoz, Breda ; Wu, Jamie...
Journal of Hepatology.  77 (2022)  - p. S449 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Systematic review of available software for multi-arm multi..:

on behalf of EU-PEARL (EU Patient-cEntric clinicAl tRial pLatforms) Consortium ; Meyer, Elias Laurin ; Mesenbrink, Peter...
Trials.  22 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
13

Predicting advanced fibrosis using non-invasive clinical te..:

Mesenbrink, Peter ; Barritt, A. Sidney ; Loomba, Rohit...
Journal of Hepatology.  73 (2020)  - p. S431-S432 , 2020
Link: https://doi.org/10.1016/..
 
?
14

The Evolution of Master Protocol Clinical Trial Designs: A ..:

Meyer, Elias Laurin ; Mesenbrink, Peter ; Dunger-Baldauf, Cornelia...
Clinical Therapeutics.  42 (2020)  7 - p. 1330-1360 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Clinical Study Design to Assess Both Short- and Long-term E..:

Yuan, Jiacheng ; Mesenbrink, Peter ; Zhou, Jihao...
Therapeutic Innovation & Regulatory Science.  52 (2018)  6 - p. 690-695 , 2018
Link: https://doi.org/10.1177/..
 
1-15